Andreas Sommer,Chengzhi Zhang,John Carter,John Arthur,Margaret Bradbury,Thomas Gant,Manouchehr Shahbaz
申请号：
US14479823
公开号：
US20150004231A1
申请日:
2014.09.08
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention relates to new pharmaceutical compositions comprising benzoquinoline compounds, and methods to inhibit vesicular monoamine transporter 2 (VMAT2) activity in a subject for the treatment of chronic hyperkinetic movement disorders.
